1. MARKETS
  2. SECTOR : OTHERS
  3. INDUSTRY : OTHERS
  4. CAPSOVISION INC.
CapsoVision Inc. XNAS: CV
Download real time
4.78 -0.10 (-2.05%)
39.36% Gain from 52W Low
9,871
XNAS Volume

XNAS 03 Nov, 2025 4:30 PM (EST)

Watchlist

Portfolio

Alert


Insider Trading disclosures for CapsoVision Inc.

The latest disclosure was made by Hui Ying Kuo in CapsoVision Inc. where a trade of 2,887 Restricted Stock Unit (RSU) done was reported to US exchanges on Sept. 15, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Hui Ying Kuo Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2025 2,887 2,887 - - Restricted Stock Unit (RSU)
Michele Harari Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2025 2,887 2,887 - - Restricted Stock Unit (RSU)
Wen-Herng Henry King Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2025 2,887 2,887 - - Restricted Stock Unit (RSU)
Joanne Imperial Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2025 2,887 2,887 - - Restricted Stock Unit (RSU)
Julia S. Gouw Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Sep 2025 2,887 2,887 - - Restricted Stock Unit (RSU)
Rebecca Petersen Director of Clinical Affairs Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Aug 2025 17,327 3,694 - - Stock Option (right to buy)
Rebecca Petersen Director of Clinical Affairs Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.37 per share. 18 Aug 2025 24,834 24,834 - 0.4 9,097 Common Stock
Rebecca Petersen Director of Clinical Affairs Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Aug 2025 7,507 0 - - Stock Option (right to buy)
Hui Ying Kuo Director 03 Jul 2025 10,354 10,354 - - Common Stock
Kang-Huai Johnny Wang Director, See Remarks 03 Jul 2025 11,111 0 - - Series D Preferred Stock
Hui Ying Kuo Director 03 Jul 2025 34,482 0 - - Series H Preferred Stock
Wen-Herng Henry King Director 03 Jul 2025 20,710 20,710 - - Common Stock
Wen-Herng Henry King Director 03 Jul 2025 68,966 0 - - Series H Preferred Stock
Kang-Huai Johnny Wang Director, See Remarks 03 Jul 2025 1,407,407 0 - - Series A Preferred Stock
Kang-Huai Johnny Wang Director, See Remarks 03 Jul 2025 35,947 0 - - Series H Preferred Stock
Kang-Huai Johnny Wang Director, See Remarks 03 Jul 2025 33,707 0 - - Series C-1 Preferred Stock
Kang-Huai Johnny Wang Director, See Remarks 03 Jul 2025 446,896 721,732 - - Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters